(COSM) Cosmos Health - Ratings and Ratios

Cosmos Health Inc. (NASDAQ:COSM) is a U.S.-based company specializing in the manufacturing, development, and distribution of branded nutraceutical and healthcare products. Established in 2009 and headquartered in Chicago, Illinois, the company operates primarily in Greece, the United Kingdom, Croatia, Bulgaria, the Cayman Islands, and Cyprus. Its product portfolio includes prescription and over-the-counter (OTC) medications, vitamins, minerals, dietary supplements, medical devices, baby products, and other health-related items. These products are marketed under the Sky Premium Life and Mediterranation brand names, targeting wholesale distributors, healthcare providers, clinics, government agencies, and independent pharmacies. The companys distribution network relies on independent wholesale distributors to reach its customer base.

From a technical perspective, COSM has shown a declining trend over the past 200 days, with its SMA 20 and SMA 50 below the SMA 200. The stock is currently trading at $0.51, below its short-term and medium-term moving averages. The ATR of 0.08 indicates low volatility, suggesting a stable but bearish trajectory in the near term. The average 20-day volume of 304,217 shares reflects moderate trading activity.

Fundamentally, the company has a market capitalization of $13.72 million, with a price-to-book (P/B) ratio of 0.37, indicating undervaluation relative to its book value. The forward P/E of 56.18 suggests high expectations for future earnings, though the current P/E is negative due to operating losses. The price-to-sales (P/S) ratio of 0.24 points to undervaluation relative to revenue. However, the return on equity (RoE) of -58.30% highlights significant profitability challenges.

Ticker Symbol: COSM Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care Distributors Average Volume 20d: 304217 Last Price: 0.51 SMA 20: 0.59 SMA 50: 0.66 SMA 200: 0.84 ATR: 0.08 Market Cap: 13.72M USD P/E: 0.00 P/E Forward: 56.18 P/B: 0.37 P/S: 0.24 RoE: -58.30 3-Month Forecast: Based on the technical and fundamental data, COSM is expected to remain under pressure in the short term, with potential sideways movement due to low volatility. The bearish crossover of the SMA 20 below the SMA 50 and SMA 200 suggests limited upside momentum. However, if the company demonstrates improved profitability or announces positive catalysts, the stock could experience a modest recovery, particularly if the forward P/E expectations are met. Without such developments, the stock may continue to trade weakly, reflecting its current financial challenges.